Nmnat1 protects neuronal function without altering phospho‐tau pathology in a mouse model of tauopathy
Erik S. Musiek(Washington University in St. Louis), David M. Holtzman(Hope Center for Neurological Disorders), Yinong Wang(China Agricultural University), Joseph P. Culver(Washington University in St. Louis), Samantha L. Finn(Prevent Alzheimer’s Disease 2020), Yo Sasaki(SHOWA Medical University), Adam Q. Bauer(Washington University in St. Louis), Risham Singh(Prevent Alzheimer’s Disease 2020), David D. Xiong(Hope Center for Neurological Disorders), Tirth K. Patel(Michigan Medicine), Jeffrey Milbrandt(James S. McDonnell Foundation)
Cited by 21
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Alzheimer disease
|Nature Reviews Disease Primers|2021|2.4k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k